The Conversation (0)
- Cantor Global Healthcare Conference, September 3 at 8:00 am EST
- Wells Fargo Healthcare Conference, September 4 at 8:45 am EST
- Morgan Stanley Global Healthcare Conference, September 9 at 11:30 am EST
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at upcoming investor conferences in September .
An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/ . An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California -based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com .
| Contacts: | |
| Investors | Media |
| Traci McCarty | Marni Kottle |
| (415) 455-7558 | (650) 374-2803 |
View original content to download multimedia: https://www.prnewswire.com/news-releases/biomarin-to-participate-in-upcoming-investor-conferences-302539513.html
SOURCE BioMarin Pharmaceutical Inc.
View original content: 